ORTX Annual SG&A
$10.60 M
-$44.30 M-80.69%
31 December 2022
Summary:
As of January 30, 2025, ORTX annual selling, general & administrative expenses is $10.60 million, with the most recent change of -$44.30 million (-80.69%) on December 31, 2022. During the last 3 years, it has fallen by -$46.62 million (-81.47%).ORTX Selling, General & Administrative Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ORTX Quarterly SG&A
$11.61 M
+$617.00 K+5.61%
30 September 2023
Summary:
As of January 30, 2025, ORTX quarterly selling, general & administrative expenses is $11.61 million, with the most recent change of +$617.00 thousand (+5.61%) on September 30, 2023. Over the past year, it has increased by +$6000.00 (+0.05%).ORTX Quarterly SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ORTX TTM SG&A
-$3.72 B
-$72.92 M-2.00%
30 September 2023
Summary:
As of January 30, 2025, ORTX TTM selling, general & administrative expenses is -$3.72 billion, with the most recent change of -$72.92 million (-2.00%) on September 30, 2023. Over the past year, it has dropped by -$3.77 billion (-7287.05%).ORTX TTM SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ORTX Selling, General & Administrative Expenses Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -80.7% | +0.1% | -7287.1% |
| 3 y3 years | -81.5% | -10.4% | -5621.9% |
| 5 y5 years | +77.1% | +55.5% | -6593.8% |
ORTX Selling, General & Administrative Expenses High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | ||||||
| 5 y | 5-year | ||||||
| alltime | all time | -83.7% | -42.4% | -5519.7% |
Orchard Therapeutics Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2023 | - | $11.61 M(+5.6%) | $44.34 M(+0.0%) |
| June 2023 | - | $10.99 M(-1.3%) | $44.33 M(-5.8%) |
| Mar 2023 | - | $11.13 M(+5.0%) | $47.07 M(-4.4%) |
| Dec 2022 | $10.60 M(-80.7%) | $10.60 M(-8.6%) | $49.23 M(-4.8%) |
| Sept 2022 | - | $11.60 M(-15.5%) | $51.70 M(-2.7%) |
| June 2022 | - | $13.73 M(+3.2%) | $53.14 M(-1.0%) |
| Mar 2022 | - | $13.30 M(+1.8%) | $53.67 M(-1.4%) |
| Dec 2021 | $54.91 M(-15.5%) | $13.07 M(+0.2%) | $54.42 M(-5.5%) |
| Sept 2021 | - | $13.04 M(-8.6%) | $57.58 M(+0.1%) |
| June 2021 | - | $14.26 M(+1.5%) | $57.50 M(-2.4%) |
| Mar 2021 | - | $14.05 M(-13.4%) | $58.89 M(-9.4%) |
| Dec 2020 | $64.99 M | $16.23 M(+25.2%) | $64.99 M(-3.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2020 | - | $12.96 M(-17.3%) | $67.29 M(-1.8%) |
| June 2020 | - | $15.66 M(-22.3%) | $68.56 M(+3.0%) |
| Mar 2020 | - | $20.14 M(+8.7%) | $66.57 M(+16.3%) |
| Dec 2019 | $57.22 M(+82.4%) | $18.53 M(+30.3%) | $57.22 M(+13.0%) |
| Sept 2019 | - | $14.22 M(+4.0%) | $50.64 M(+15.4%) |
| June 2019 | - | $13.67 M(+26.7%) | $43.88 M(+16.6%) |
| Mar 2019 | - | $10.79 M(-9.7%) | $37.63 M(+20.0%) |
| Dec 2018 | $31.37 M(+424.1%) | $11.95 M(+60.1%) | $31.37 M(+61.6%) |
| Sept 2018 | - | $7.47 M(+0.6%) | $19.41 M(+62.5%) |
| June 2018 | - | $7.42 M(+63.9%) | $11.95 M(+163.9%) |
| Mar 2018 | - | $4.53 M | $4.53 M |
| Dec 2017 | $5.99 M(+99.7%) | - | - |
| Dec 2016 | $3.00 M | - | - |
FAQ
- What is Orchard Therapeutics annual selling, general & administrative expenses?
- What is the all time high annual SG&A for Orchard Therapeutics?
- What is Orchard Therapeutics annual SG&A year-on-year change?
- What is Orchard Therapeutics quarterly selling, general & administrative expenses?
- What is the all time high quarterly SG&A for Orchard Therapeutics?
- What is Orchard Therapeutics quarterly SG&A year-on-year change?
- What is Orchard Therapeutics TTM selling, general & administrative expenses?
- What is the all time high TTM SG&A for Orchard Therapeutics?
- What is Orchard Therapeutics TTM SG&A year-on-year change?
What is Orchard Therapeutics annual selling, general & administrative expenses?
The current annual SG&A of ORTX is $10.60 M
What is the all time high annual SG&A for Orchard Therapeutics?
Orchard Therapeutics all-time high annual selling, general & administrative expenses is $64.99 M
What is Orchard Therapeutics annual SG&A year-on-year change?
Over the past year, ORTX annual selling, general & administrative expenses has changed by -$44.30 M (-80.69%)
What is Orchard Therapeutics quarterly selling, general & administrative expenses?
The current quarterly SG&A of ORTX is $11.61 M
What is the all time high quarterly SG&A for Orchard Therapeutics?
Orchard Therapeutics all-time high quarterly selling, general & administrative expenses is $20.14 M
What is Orchard Therapeutics quarterly SG&A year-on-year change?
Over the past year, ORTX quarterly selling, general & administrative expenses has changed by +$6000.00 (+0.05%)
What is Orchard Therapeutics TTM selling, general & administrative expenses?
The current TTM SG&A of ORTX is -$3.72 B
What is the all time high TTM SG&A for Orchard Therapeutics?
Orchard Therapeutics all-time high TTM selling, general & administrative expenses is $68.56 M
What is Orchard Therapeutics TTM SG&A year-on-year change?
Over the past year, ORTX TTM selling, general & administrative expenses has changed by -$3.77 B (-7287.05%)